ABSTRACT The actions of the phenothiazines chlorpromazine, prochlorperazine, and trifluoperazine were studied on the acetylcholine receptor-ionic channel complex of frog and rat skeletal muscle and of Torpedo californica to determine their role in pharmacological desensitization and their interactions with different states of the receptor-ionic channel complex. The phenothiazines depressed the peak amplitude ofspontaneous and evoked endplate currents while having negligible effect on the decay time constants. Mean channel lifetime and single channel conductance were not altered by these drugs. They also produced a frequencydependent depression ofthe peak amplitude ofendplate potentials evoked by repetitive microiontophoresis at the extrajunctional region. In addition, these drugs enhanced the ability of carbamoylcholine to displace '2I-labeled a-bungarotoxin from receptor-rich membrane preparations of T. californica when used in concentrations that had no effect on '25I-labeled a-bungarotoxin binding alone (10 FM). Similarly, the phenothiazines inhibited the binding of tritiated ionic channel ligands, such as phencyclidine and perhydrohistrionicotoxin, a process also enhanced by the presence of carbamoylcholine. These data suggest that the phenothiazines augment agonist-induced desensitization primarily by interacting with the receptor-ionic channel complex prior to channel opening.
alone (10 FM) . Similarly, the phenothiazines inhibited the binding of tritiated ionic channel ligands, such as phencyclidine and perhydrohistrionicotoxin, a process also enhanced by the presence of carbamoylcholine. These data suggest that the phenothiazines augment agonist-induced desensitization primarily by interacting with the receptor-ionic channel complex prior to channel opening.
Desensitization of the nicotinic receptor at the neuromuscular junction has been described as a gradual decrease in depolarization upon continued application of agonist (1) . The progressive decrease in endplate responsiveness has been suggested to be associated with a concomitant increase in receptor affinity for the agonist (2, 3) . In light of these observations, desensitization has been proposed to result from an agonist-induced conformational change, generating a nonconducting species of the acetylcholine (AcCho) receptor-ionic channel complex (4) (5) (6) .
Drugs such as meproadifen (6, 7) and chlorpromazine (ClPZ) (8) (9) (10) (11) have been shown to produce a phenomenon resembling desensitization. These drugs produce a progressive decrease in endplate responsiveness to AcCho under conditions in which the agonist alone did not produce desensitization. The similarity of the pharmacologically enhanced desensitization to the phenomenon initially described by Thesleff (1) and Katz and Thesleff (4) is further borne out by the observation that these agents increase the affinity of the agonist for its binding site. Despite these similarities, it remains unclear whether these two phenomena proceed by identical processes. One point of controversy is whether the interaction between these agents and the receptor-ionic channel complex that produces these effects occurs before (8) or after (9) opening of the ionic channel.
The objective of the present investigation is to provide an electrophysiological and biochemical analysis ofthe action ofthe phenothiazines CIPZ, trifluoperazine (TFP), and prochlorperazine (PCIP) on the nicotinic receptor-ionic channel complex ofthe frog and rat neuromuscular synapse as well as ofthe electric organ of Torpedo californica and to establish the mechanism(s) by which the phenothiazines and other agents that enhance desensitization act.
METHODS AND MATERIALS
Electrophysiology. Endplate currents (EPCs), miniature endplate currents (MEPCs), and AcCho-induced noise were recorded from glycerol-treated (12, 13) , voltage-clamped superficial fibers of cutaneous pectoris muscles of the frog Rana pipiens as described (14) (15) (16) . MEPCs and AcCho-induced noise were recorded in the presence of0.3 ,uM tetrodotoxin (Sigma). Endplate potentials (EPPs) evoked by iontophoretic application of AcCho were recorded from superficial fibers of denervated rat soleus and extensor digitorum longus muscles as described (17) . Ten "2I-Labeled a-bungarotoxin (125I-BGT; [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Ci/,ug, New England Nuclear; 1 Ci = 3.7 X 1010 becquerels) binding to the nicotinic AcCho receptor was measured at room temperature by using a filtration procedure as described (18, 19) .
RESULTS
Effects of Phenothiazines on Nerve-Evoked EPCs. At a membrane potential of -90 mV, CIPZ in concentrations of 3, 5, and 7.5 ,uM depressed significantly the peak amplitude of the EPC to 63%, 51%, and 30% of control, whereas the decay Abbreviations: AcCho, acetylcholine; BGT, a-bungarotoxin; CIPZ, chlorpromazine; EPC, endplate current; EPP, endplate potential; H12-HTX, perhydrohistrionicotoxin; MEPC, miniature endplate current; PClP, prochlorperazine; PCP, phencycidine; TFP, trifluoperazine.
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Proc. Natl. Acad. Sci. USA 80 (1983) 311 time constant of the EPC (TEPC) was only 95%, 87%, and 82% ofcontrol, respectively (Fig. 1) . PClP in concentrations of5 and 10 ,uM depressed the peak amplitude of the EPC to 88% and 32% ofcontrol, whereas the TEPC was 103% and 101% ofcontrol, respectively. TFP in concentrations of 5, 7, 10, and 20 MM depressed the peak amplitude to 62%, 31%, 18%, and 3% of control, whereas the TEpc was 100%, 82%, 74%, and 81% ofcontrol, respectively. For each of these drugs, the current-voltage relationships remained linear at all concentrations used. No differences in the peak amplitude of the EPC were found at any membrane potential betweeen -150 and -50 mV when the membrane potential was changed in either the hyperpolarizing or the depolarizing direction (i.e., no hysteresis was observed) (20) . Thus, ClPZ, PCIP, and TFP do not affect the voltage-and time-dependent nature of the EPC.
Effects of Phenothiazines on MEPCs. Fig. 2 shows the effects of the phenothiazines on the peak amplitude ( Fig. 2 A-C) and the decay time constant of the MEPC (TMEPC) (Fig. 2 D- F). ClPZ in concentrations of2 and 5 MM depressed (P < 0.05) the peak amplitude of the MEPC at membrane potentials of -60, -90, and -120 mV, whereas the TMEPC was depressed (P < 0.05) only by 5 AtM at membrane potentials of -90 and -120 mV, respectively. After 5 AM ClPZ, the peak amplitude was 36% and 31% of control, whereas the TMEPC was 70% and 65% of control at membrane potentials of -90 and -120 mV, respectively. At 2 AM, PCIP depressed (P < 0.05) the peak amplitude at a membrane potential of -90 mV and, at 5 MM, it depressed the peak amplitude at membrane potentials of -60, -90, and -120 mV. TMEPC was not affected by PCIP at any ofthe concentrations or membrane potentials studied. TFP at a concentration of 5 MM depressed (P < 0.05) the peak amplitude at membrane potentials of -90 and -120 mV, whereas TMEPC was depressed (P < 0.05) by concentrations of 2 and 5 ,M at a membrane potential of -60 mV. In the presence of 5 ,AM TFP, the peak amplitude was 55% and 52% of control at membrane potentials of -90 and -120 mV, respectively. At a membrane potential of -60 mV, the TMEPC was 80% Fig. 3 , there was no time dependence under control conditions in the peak amplitude of consecutive EPPs evoked by iontophoretic application of AcCho. The mean peak amplitudes of the second to the tenth EPPs in a train of 10 EPPs did not vary by >10% from the amplitude of the first EPP when elicited at frequencies from 0.5 to 5.0 Hz. However, all three phenothiazines induced a timedependent depression of the peak amplitude of consecutively evoked EPPs. In the presence of 1 and 5 MM ClPZ, the mean (± SEM) peak amplitude ofthe tenth EPP ofa train of 10 EPPs evoked at 0.5 Hz was 96% ± 5% and 69% ± ]1% of control, respectively (Fig. 3A) . The time-dependent depression of the peak amplitude ofthe EPP was more pronounced at higher frequencies. At 1 and 5 ,M ClPZ, the mean (± SEM) amplitude ofthe tenth EPP ofa train of 10 EPPs evoked at 5.0 Hz was 68% ± 3% and 22% ± 2% of control, respectively. Similar effects were observed with PC1P ( Fig. 3B) and TFP (Fig. 3C ). At concentrations of 1 and 5 MM PC1P, the mean (± SEM) peak amplitude ofthe tenth EPP ofa train of 10 EPPs evoked at 0.5 Hz was 98% ± 2% and 71% ± 2%, and at 5.0 Hz it was 96% ± 2% and 59% ± 1% of control, respectively. At concentrations of 1 and 5 MM TFP, the mean (± SEM) peak amplitude ofthe tenth EPP ofa train of 10 EPPs evoked at 0.5 Hz was 81% ± 8% and 33% ± 3%, and at 5.0 Hz it was 81% ± 3% and 13% ± 1% of control, respectively.
Effects of Phenothiazines on Ionic Channel and AcCho Receptor Binding. As summarized in Table 1 values were in the range of0.3 to 1.4 AM. In contrast, the phenothiazines were weak inhibitors of 3H-labeledAcCho and I-BGT binding to the AcCho receptor. None of the three compounds inhibited receptor binding at 0.1 mM. However, the phenothiazines. increased carbamoylcholine's affinity for the receptor, as identified by the increased ability of the agonist to inhibit the binding of 15I-BGT (Fig. 4) (8, 9) . Second, the phenothiazines, in concentrations that have no effect on BGT binding alone, enhance the ability ofcarbamoylcholine to displace BGT from the AcCho receptor. This suggests that the-phenothiazines may produce a relative increase in the affinity ofthe AcCho receptor for the agonist compared with that for the antagonist. Enhanced affinity ofthe AcCho receptor for agonist coupled with a depression of ion flux have been shown to occur upon exposure of receptor-rich. Torpedo membrane preparations to agonist, suggesting that formation of a high affinity state of the AcCho receptor is a characteristic phenomenon of desensitization (3, 4) ; Because phenothiazines produced both a frequency-dependent decrease in endplate responsiveness and an apparent relative increase in receptor affinity for agonist, it seems-likely that these drugs enhance agonist-induced desensitization at the neuromuscular junction.
The effects of the phenothiazines on EPCs and spontaneous MEPCs may explain how these drugs interact with the receptor-ionic channel complex and cause the pharmacological desensitization. All three phenothiazines depressed the peak amplitude of the EPC and MEPC at concentrations that had little or no effect on the TEPC and TMEPC. At higher concentrations TEPC and TMEPC were decreased, but always to a lesser degree than were the peak amplitudes of EPCs and MEPCs. Inasmuch as the TEPC and TMEPc reflect Tr (21-23), the phenothiazines would appear to be only weak blockers of the ionic channel in its "open" conformation. The minimal effect of the phenothiazines on the TEPC and TMEPC is consistent with the observation that these drugs had no significant effect on TI or y, as determined by noise analysis. However, other drugs that produce pharmacological desensitization do not share this profile of effects. Although meproadifen also produces a depression of the peak amplitude of the EPC with little or no effect on the TEPC (6) , histrionicotoxin causes a marked reduction in both peak amplitude and TEPC (24) . Thus, contrary to the hypothesis of Anwyl and Narahashi (9), these data suggest that a drug interaction with the receptor-ionic channel complex in its open conformation may not be essential for the expression of pharmacological desensitization (see step 3 in the reaction scheme below, in which A represents the agonist, D represents the drug, and RI, RI*, and RI' represent the receptor-ionic channel 
primarily through an interaction with the receptor-ionic channel complex prior to channel opening. It has been proposed that, even in the absence ofagonist, CIPZ and meproadifen stabilize a species of the receptor-ionic channel complex that has a high affinity for agonist (7, 10, 25) . If this high affinity species were similar to the high affinity species that is incapable of activation and is produced by exposure to agonist alone, then the phenothiazines could be producing a shift in the equilibrium concentrations of receptor-ionic channel complexes in favor of 
